WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: 330350)
South Korea
· Delayed Price · Currency is KRW
6,310.00
+90.00 (1.45%)
Nov 15, 2024, 9:00 AM KST
WITHUS PHARMACEUTICAL Co.,LTD. Revenue
WITHUS PHARMACEUTICAL Co.,LTD. had revenue of 26.26B KRW in the quarter ending June 30, 2024, with 44.82% growth. This brings the company's revenue in the last twelve months to 98.27B, up 49.37% year-over-year. In the year 2023, WITHUS PHARMACEUTICAL Co.,LTD. had annual revenue of 80.12B with 23.87% growth.
Revenue (ttm)
98.27B
Revenue Growth
+49.37%
P/S Ratio
0.84
Revenue / Employee
812.18M
Employees
121
Market Cap
82.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 80.12B | 15.44B | 23.87% |
Dec 31, 2022 | 64.68B | 7.26B | 12.65% |
Dec 31, 2021 | 57.42B | 4.01B | 7.51% |
Dec 31, 2020 | 53.41B | 1.01B | 1.93% |
Jun 30, 2020 | 52.39B | 661.12M | 1.28% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition